Cancer Immunology Immunotherapy. 2014;63(1):21-8.Ames E, Murphy WJ. Advantages and clinical applications of natural killer cells in cancer immunother- apy. Cancer immunology, immunotherapy: CII. 2013. doi: 10.1007/s00262-013-1469-8 PMID: 23989217....
Despite great success in cancer immunotherapy,immune checkpoint-targeting drugs are not the most popular weapon in the armory of cancer therapy.Accumulating evidence suggests that the tumor immune microenvironment plays a critical role in anticancer immunity,which may result in immune checkpoint blockade ...
while an additive or even synergistic effect can be realized. Combination treatment regimens are aimed at increasing the efficiency and, above all, at the complete eradication of the tumor, which can be achieved either by suppressing the survival mechanisms in ...
immunotherapy, and precision-based equipment to treat diseases like cancer more effectively. Early detection techniques have also improved drastically, and this has increased detection rates. Precision based technology leading to precise treatment protocols have reduced hospital stay for most of the...
An innovative path for cancer research and treatment would be possible through the identification of novel therapeutic drugs that can specifically inhibit oncogenic miRNAs [54]. Since an imbalance in miRNA expression levels is associated with the development of cancer, miRNA-based cancer therapies are ...
Despite great success in cancer immunotherapy, immune checkpoint-targeting drugs are not the most popular weapon in the armory of cancer therapy. Accumulating evidence suggests that the tumor immune microenvironment plays a critical role in anti-cancer i
IMMUNOTHERAPYIMMUNOTHERAPY LEUKEMIASLEUKEMIASLEUKEMIASLEUKEMIAS LUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCER LYMPHOMASLYMPHOMASLYMPHOMASLYMPHOMAS MPNs MULTIPLE MYELOMA NTRK GENE FUSIONS SARCOMA SKIN CANCERSSKIN CANCERS THYROID CANCERS Spotlight NEWS CONFERENCES MEDIA PUBLICATIONS CASE-BASED ROUNDTABLE PARTNE...
Kalman Unveils Insights on Thyroid Cancer Prognosis and Treatments Evaluating the Impact of Genetic Mutations on Prostate Cancer Survival Rates Improving Outcomes in RCC Brain Metastasis With SRS and Immunotherapy Mehta on the Phase 3 METIS Trial of TTFields for Brain Metastases in NSCLC ...
Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancer. Despite a decrease in gastric cancer incidence, the development of novel biologic agents and combined therapeutic strategies, the prognosis of gastric canc... Daniela,Cornelia...
This review provides an in-depth discussion of the application and therapeutic potential of CAR-iNKT cells in cancer immunotherapy, with a focus on their advantages over conventional CAR-T cells and their role in addressing the challenges of solid tumor treatment....